News
News Center
2021-12-20
On December 18, 2021, the 5th session of the 4th Council Meeting of the China Association of Traditional Chinese Medicine was held in Beijing. During the meeting, the 2021 Annual Information on the TCM Industry was officially unveiled via live-streaming online. Notably, Jiuzhitang Shuxuetong Injection, Liuwei Dihuang Wan, and Tianma Gouteng Granules proudly made it onto the 2021 List of Clinically Valuable Brands of Traditional Chinese Medicines!
+
2021-12-20
Jiuzhitang ranked 26th among the Top 100 Traditional Chinese Medicine Brands in 2021!
On December 18, 2021, the 5th session of the 4th Council Meeting of the China Association of Traditional Chinese Medicine was held in Beijing. During the meeting, Liu Zhanglin, Vice President of the China Association of Traditional Chinese Medicine, officially unveiled the 2021 Top 100 List of Traditional Chinese Patent Medicines via online livestream. Notably, Jiuzhitang Co., Ltd. was honorably recognized, ranking 26th on the list!
+
2021-12-07
On December 3, the General Office of the People's Government of Yuexiu District, Guangzhou, officially issued the "Notice on the '14th Five-Year' Plan for Science and Technology Innovation and Strategic Emerging Industry Development in Yuexiu District, Guangzhou."
+
2021-12-06
Support innovative R&D initiatives! Companies can receive up to 100 million in funding annually.
Supporting innovative drug research and development. For new drugs that initiate clinical trials and are subsequently translated for implementation in Daxing District, phased support will be provided based on their R&D progress.
+
2021-12-01
All about stem cell therapy for AIDS
In recent years, clinical studies exploring the use of mesenchymal stem cells to treat AIDS have been steadily advancing, and the number of research findings being published is also growing. We believe that in the future, more HIV/AIDS patients will benefit from this innovative approach.
+
2021-11-26
Jiuzhitang Maker was invited as one of the drafting organizations, with Chairman Zhang Quancheng and General Manager Gao Yansong participating in the drafting process.
+
2021-11-25
Let's strive to achieve a batch of groundbreaking, original breakthroughs in areas like stem cell therapy and regenerative medicine! Beijing has released the "Beijing Plan for Building an International Science and Technology Innovation Center during the 14th Five-Year Period."
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy